We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
-12.51%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
AUM
$767M
AUM Growth
-$135M
Cap. Flow
-$5.63M
Cap. Flow %
-0.73%
Top 10 Hldgs %
44.3%
Holding
1,179
New
45
Increased
120
Reduced
162
Closed
82

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$5.77M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.96M
3
NKE icon
Nike
NKE
+$1.53M
4
V icon
Visa
V
+$1.36M
5
MSFT icon
Microsoft
MSFT
+$1.29M

Sector Composition

Rank Sector Weight
1 Financials 23.44%
2 Consumer Discretionary 16.4%
3 Technology 15.93%
4 Communication Services 11.81%
5 Healthcare 10.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTE icon
1076
Gran Tierra Energy
GTE
$349M
$65 ﹤0.01%
3
GCVRZ
1077
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$62 ﹤0.01%
130
OPTT icon
1078
Ocean Power Technologies
OPTT
$46.2M
$50 ﹤0.01%
7
TPST icon
1079
Tempest Therapeutics
TPST
$17.5M
0
GENE
1080
DELISTED
Genetic Technologies Ltd.
GENE
$44 ﹤0.01%
4
SRL icon
1081
Scully Royalty
SRL
$88.9M
$42 ﹤0.01%
8
LSTA icon
1082
Lisata Therapeutics
LSTA
$15.2M
$36 ﹤0.01%
1
NNVC icon
1083
NanoViricides
NNVC
$31.7M
$29 ﹤0.01%
7
FTR
1084
DELISTED
Frontier Communications Corp.
FTR
$29 ﹤0.01%
12
GRCE
1085
Grace Therapeutics
GRCE
$44.6M
$25 ﹤0.01%
1
CRIS icon
1086
Curis
CRIS
$3.61M
0
FCSC
1087
DELISTED
Fibrocell Science Inc.
FCSC
$21 ﹤0.01%
14
VIVE
1088
DELISTED
VIVEVE MED INC
VIVE
0
SNOA icon
1089
Sonoma Pharmaceuticals
SNOA
$6.27M
0
ADXS
1090
DELISTED
Advaxis Inc
ADXS
$11 ﹤0.01%
4
CYTR
1091
DELISTED
CytRx Corp
CYTR
$8 ﹤0.01%
17
OIBR.C
1092
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$6 ﹤0.01%
4
DRIO icon
1093
DarioHealth
DRIO
$66.3M
0
PALI icon
1094
Palisade Bio
PALI
$349M
0
APEN
1095
DELISTED
Apollo Endosurgery, Inc.
APEN
$3 ﹤0.01%
1
MBOT icon
1096
Microbot Medical
MBOT
$99.4M
$2 ﹤0.01%
1
ACM icon
1097
Aecom
ACM
$8.9B
-265
Closed -$8.65K
ALK icon
1098
Alaska Air
ALK
$4.72B
-90
Closed -$6.2K
APVO icon
1099
Aptevo Therapeutics
APVO
$4.27M
0
-$229
AWK icon
1100
American Water Works
AWK
$27.5B
-50
Closed -$4.4K

Similar funds

RBC Europe's Q4 2018 Portfolio in Review

As of Q4 2018, RBC Europe held 1,179 positions worth $767M, down 15% from $901M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

RBC Europe's Q4 2018 filing shows 45 new, 120 increased, 162 reduced and 82 closed positions. Its largest new stake was Cigna: 3,637 shares worth $691K. The largest sale was Meta Platforms (Facebook), an estimated $4.72M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Technology.

  • RBC Europe's largest Q4 2018 buy was Cigna: 3,637 shares worth $691K.
  • RBC Europe added most to Berkshire Hathaway Class B in Q4 2018, an estimated $5.77M increase.
  • RBC Europe's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $4.72M.
  • RBC Europe fully exited Mimecast Limited in Q4 2018, selling an estimated $4.19M.
  • RBC Europe's ten largest holdings make up 44% of its $767M portfolio in Q4 2018.
  • RBC Europe opened 45 new positions and closed 82 in Q4 2018.
  • RBC Europe's portfolio value fell 15% quarter-over-quarter to $767M.

Based on RBC Europe's 13F filing for Q4 2018, filed 9 Nov 2023.